AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review

AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review

Disabling limb spasticity can result from stroke, traumatic brain injury or other disorders causing upper motor neuron lesions such as multiple sclerosis. Clinical studies have shown that abobotulinumtoxinA (AboBoNT-A) therapy reduces upper and lower limb spasticity in adults. However, physicians ma...

Full description

Bibliographic Details
Main Authors: Alexis Schnitzler, Clément Dince, Andreas Freitag, Ike Iheanacho, Kyle Fahrbach, Louis Lavoie, Jean-Yves Loze, Anne Forestier, David Gasq
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Toxins
Subjects:
botulinum toxins
muscle hypertonia
muscle spasticity
injections
intramuscular
central nervous system diseases
Online Access:https://www.mdpi.com/2072-6651/14/11/734

Internet

https://www.mdpi.com/2072-6651/14/11/734

Similar Items